These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37749420)
1. Training New DMC Members: A Call to Action. Rockhold F; Mahaffey K; DeMets D Ther Innov Regul Sci; 2024 Mar; 58(2):234-235. PubMed ID: 37749420 [TBL] [Abstract][Full Text] [Related]
2. Issues in data monitoring and interim analysis of trials. Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA; Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038 [TBL] [Abstract][Full Text] [Related]
3. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative. Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947 [TBL] [Abstract][Full Text] [Related]
4. Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory. Fleming TR; Wittes J; Fiuzat M; Bristow MR; Rockhold FW; Connor JT; Saville BR; Claggett B; Cavagna I; Abraham WT; Cook TD; Lindenfeld J; O'Connor C; DeMets DL; JACC Heart Fail; 2024 Aug; 12(8):1317-1327. PubMed ID: 38530701 [TBL] [Abstract][Full Text] [Related]
5. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study. Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484 [TBL] [Abstract][Full Text] [Related]
6. Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study. Hinga A; Ibrahim A; Vintimilla D; Jones M; Eckstein L; Rid A; Shah SK; Kamuya D BMJ Glob Health; 2024 Aug; 9(8):. PubMed ID: 39182924 [TBL] [Abstract][Full Text] [Related]
7. Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials. Fleming TR; Hennekens CH; Pfeffer MA; DeMets DL J Biopharm Stat; 2014; 24(5):968-75. PubMed ID: 24926941 [TBL] [Abstract][Full Text] [Related]
8. Data monitoring in randomized controlled trials: surveys of recent practice and policies. Clemens F; Elbourne D; Darbyshire J; Pocock S; Clin Trials; 2005; 2(1):22-33. PubMed ID: 16279576 [TBL] [Abstract][Full Text] [Related]
10. A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting. Major-Pedersen A; McCullen MK; Sabol ME; Adetunji O; Massaro J; Neugut AI; Sosa JA; Hollenberg AN Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):9-16. PubMed ID: 33179845 [TBL] [Abstract][Full Text] [Related]
11. Stakeholders' Perspectives on Current Issues in Data Monitoring Committees. Cartwright MJ; Friede T; Lawrence D; May E; Mütze T; Roes K Biom J; 2024 Oct; 66(7):e202300384. PubMed ID: 39308116 [TBL] [Abstract][Full Text] [Related]
12. On the independence of data monitoring committee in adaptive design clinical trials. Chow SC; Corey R; Lin M J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119 [TBL] [Abstract][Full Text] [Related]
13. The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors. Bhattacharyya A; Gallo P; Crisp A; LaVange L; Molenberghs G; Pétavy F; Seltzer J Biom J; 2019 Sep; 61(5):1232-1241. PubMed ID: 30589102 [TBL] [Abstract][Full Text] [Related]
14. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Sydes MR; Altman DG; Babiker AB; Parmar MK; Spiegelhalter DJ; Clin Trials; 2004 Feb; 1(1):48-59. PubMed ID: 16281462 [TBL] [Abstract][Full Text] [Related]
15. Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19. Sandercock PAG; Darbyshire J; DeMets D; Fowler R; Lalloo DG; Munavvar M; Staplin N; Warris A; Wittes J; Emberson JR Trials; 2022 Oct; 23(1):881. PubMed ID: 36258219 [TBL] [Abstract][Full Text] [Related]
16. Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases. Filippatos GS; de Graeff P; Bax JJ; Borg JJ; Cleland JG; Dargie HJ; Flather M; Ford I; Friede T; Greenberg B; Henon-Goburdhun C; Holcomb R; Horst B; Lekakis J; Mueller-Velten G; Papavassiliou AG; Prasad K; Rosano GM; Severin T; Sherman W; Stough WG; Swedberg K; Tavazzi L; Tousoulis D; Vardas P; Ruschitzka F; Anker SD Eur J Heart Fail; 2017 Apr; 19(4):449-456. PubMed ID: 28271595 [TBL] [Abstract][Full Text] [Related]
17. Issues in regulatory guidelines for data monitoring committees. DeMets D; Califf R; Dixon D; Ellenberg S; Fleming T; Held P; Julian D; Kaplan R; Levine R; Neaton J; Packer M; Pocock S; Rockhold F; Seto B; Siegel J; Snapinn S; Stump D; Temple R; Whitley R Clin Trials; 2004; 1(2):162-9. PubMed ID: 16281888 [TBL] [Abstract][Full Text] [Related]
18. Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials. Sydes MR; Spiegelhalter DJ; Altman DG; Babiker AB; Parmar MK; Clin Trials; 2004 Feb; 1(1):60-79. PubMed ID: 16281463 [TBL] [Abstract][Full Text] [Related]
19. Responsibilities of Data Monitoring Committees: Consensus Recommendations. Bierer BE; Li R; Seltzer J; Sleeper LA; Frank E; Knirsch C; Aldinger CE; Levine RJ; Massaro J; Shah A; Barnes M; Snapinn S; Wittes J Ther Innov Regul Sci; 2016 Sep; 50(5):648-659. PubMed ID: 30231760 [TBL] [Abstract][Full Text] [Related]